These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31579817)

  • 1. No evidence of ongoing HIV replication or compartmentalization in tissues during combination antiretroviral therapy: Implications for HIV eradication.
    Bozzi G; Simonetti FR; Watters SA; Anderson EM; Gouzoulis M; Kearney MF; Rote P; Lange C; Shao W; Gorelick R; Fullmer B; Kumar S; Wank S; Hewitt S; Kleiner DE; Hattori J; Bale MJ; Hill S; Bell J; Rehm C; Grossman Z; Yarchoan R; Uldrick T; Maldarelli F
    Sci Adv; 2019 Sep; 5(9):eaav2045. PubMed ID: 31579817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer.
    Rose R; Lamers SL; Nolan DJ; Maidji E; Faria NR; Pybus OG; Dollar JJ; Maruniak SA; McAvoy AC; Salemi M; Stoddart CA; Singer EJ; McGrath MS
    J Virol; 2016 Oct; 90(20):8984-93. PubMed ID: 27466425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of integration and clonal expansion in HIV infection: live long and prosper.
    Anderson EM; Maldarelli F
    Retrovirology; 2018 Oct; 15(1):71. PubMed ID: 30352600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
    Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D
    J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy.
    Sun H; Kim D; Li X; Kiselinova M; Ouyang Z; Vandekerckhove L; Shang H; Rosenberg ES; Yu XG; Lichterfeld M
    J Virol; 2015 Nov; 89(22):11284-93. PubMed ID: 26339043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting viral reservoirs: ability of antiretroviral therapy to stop viral replication.
    Maldarelli F
    Curr Opin HIV AIDS; 2011 Jan; 6(1):49-56. PubMed ID: 21228755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy.
    Kearney MF; Spindler J; Shao W; Yu S; Anderson EM; O'Shea A; Rehm C; Poethke C; Kovacs N; Mellors JW; Coffin JM; Maldarelli F
    PLoS Pathog; 2014 Mar; 10(3):e1004010. PubMed ID: 24651464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can HIV infection be eradicated through use of potent antiviral agents?
    Josefsson L; Dahl V; Palmer S
    Curr Opin Infect Dis; 2010 Dec; 23(6):628-32. PubMed ID: 20847693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.
    Zhang L; Ramratnam B; Tenner-Racz K; He Y; Vesanen M; Lewin S; Talal A; Racz P; Perelson AS; Korber BT; Markowitz M; Ho DD
    N Engl J Med; 1999 May; 340(21):1605-13. PubMed ID: 10341272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV rebounds from latently infected cells, rather than from continuing low-level replication.
    Joos B; Fischer M; Kuster H; Pillai SK; Wong JK; Böni J; Hirschel B; Weber R; Trkola A; Günthard HF;
    Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16725-30. PubMed ID: 18936487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection.
    Lau CY; Adan MA; Maldarelli F
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking episomal HIV DNA: implications for viral persistence and eradication of HIV.
    Sharkey M
    Curr Opin HIV AIDS; 2013 Mar; 8(2):93-9. PubMed ID: 23380651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.
    Chun TW; Justement JS; Moir S; Hallahan CW; Maenza J; Mullins JI; Collier AC; Corey L; Fauci AS
    J Infect Dis; 2007 Jun; 195(12):1762-4. PubMed ID: 17492591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV Diversity and Genetic Compartmentalization in Blood and Testes during Suppressive Antiretroviral Therapy.
    Miller RL; Ponte R; Jones BR; Kinloch NN; Omondi FH; Jenabian MA; Dupuy FP; Fromentin R; Brassard P; Mehraj V; Chomont N; Poon AFY; Joy JB; Brumme ZL; Routy JP;
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.
    Zhu T; Muthui D; Holte S; Nickle D; Feng F; Brodie S; Hwangbo Y; Mullins JI; Corey L
    J Virol; 2002 Jan; 76(2):707-16. PubMed ID: 11752161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy.
    Frenkel LM; Wang Y; Learn GH; McKernan JL; Ellis GM; Mohan KM; Holte SE; De Vange SM; Pawluk DM; Melvin AJ; Lewis PF; Heath LM; Beck IA; Mahalanabis M; Naugler WE; Tobin NH; Mullins JI
    J Virol; 2003 May; 77(10):5721-30. PubMed ID: 12719565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients.
    Langford D; Marquie-Beck J; de Almeida S; Lazzaretto D; Letendre S; Grant I; McCutchan JA; Masliah E; Ellis RJ
    J Neurovirol; 2006 Apr; 12(2):100-7. PubMed ID: 16798671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
    Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
    J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.